Intelligence · Clinical Pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
- Programs
- 1,839
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
-
Telavancin Injection
CUMBERLAND PHARMACEUTICALS INC
Subarachnoid Hemorrhage, Aneurysmal
1 trial -
Telavancin Injection
CUMBERLAND PHARMACEUTICALS INC
Cystic Fibrosis
1 trial -
Telbivudine treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Telmisartan
Boehringer Ingelheim
Cardiovascular Diseases
1 trial -
Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 80 mg + 5 mg, tabletki, Telmisartan/Amlodipine/Hydrochlorothiazide, Tamloset 40 mg/5 mg tabletta, Tamloset 80 mg/10 mg tabletta, Telassmo 80 mg/10 mg tablete, Tamloset 80 mg/5 mg tabletta, Teldipin, 80 mg + 10 mg, tabletki, Telassmo 40 mg/5 mg tablete, Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 40 mg + 5 mg, tabletki, Telassmo 80 mg/5 mg tablete
Novo Nordisk A/S
Arterial hypertension
1 trial -
Temozolomide
Monte Rosa Therapeutics
Brain Neoplasms, Malignant, Primary
1 trial -
Tenofovir Alafenamide 25 MG
The First People's Hospital of Lianyungang
Chronic Hepatitis C
1 trial -
Tenofovir Alafenamide Tablets
The First People's Hospital of Lianyungang
Chronic Hepatitis b
1 trial -
Tenofovir Alafenamide fumarate 25mg Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Tenofovir disoproxil fumarate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Teriparatide
United Therapeutics Europe Ltd
Stress Fracture of Tibia or Fibula
1 trial -
Teriparatide
United Therapeutics Europe Ltd
Osteoporosis
1 trial -
Terrosa 20 micrograms/80 microliters solution for injection in pre-filled pen, Acido Alendronico Aurobindo 70 mg compresse
Gedeon Richter Australia Pty Ltd
Prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures.
1 trial -
Test preparation:Methylcholine chloroacetate for inhalation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy People
1 trial -
Test preparation:Methylcholine chloroacetate for inhalation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Asthma
1 trial -
Tetanusvaccin, suspensie voor injectie 40 IE
Disc Medicine
Systemic sclerosis, Systemic lupus erythematosus, Rheumatoid arthritis
1 trial -
Thalidomide
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
The Placebo used for the clinical trial is a sterile saline solution (0.9% w/v solution of NaCl in water) supplied in 1.25 mL pre-filled glass syringes., Shingrix suspension for injection in pre filled syringe Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Incident dementia
1 trial -
The impact of extra-fine inhalation corticosteroid particles on small-airway disease in Chronic Obstructive Pulmonary Disease (COPD): a randomized, prospective cross-over trial.
Pierre Fabre Australia Pty Ltd
Chronic Obstructive Pulmonary Disease
1 trial -
The live attenuated varicella vaccine and the inactivated hepatitis A vaccine
Sinovac Research and Development Co.,
Varicella
1 trial -
The placebo MDI is formulated as a suspension of spray-dried porous particles (consisting of 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC] and calcium chloride) in a hydrofluoroalkane propellant (HFA-134a). The placebo MDI uses the same excipients as active product but with absence of the active pharmaceutical ingredient (API)., Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension
AstraZeneca AB
Chronic Obstructive Pulmonary Disease
1 trial -
The placebo has the same composition as the investigational medicinal product alkacitrat effervescent tablet 2 g/tab (with the exception of the active substance), is manufactured by the same manufacturer (uni-pharma kleon tsetis pharmaceutical laboratory s.a) and is not sterile., ALKACITRAT Αναβράζον δισκίο 2 g/tab
Lacuna Pharma Pty Ltd
Functional Dyspepsia
1 trial -
Thoracic epidural (ropivicaine, fentanyl)
BRIGHT MINDS BIOSCIENCES INC.
Pectus Excavatum
1 trial -
Thymosin Alpha 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatitis, Acute Necrotizing
1 trial -
Ticagrelor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
Ticagrelor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Ticagrelor followed with Methoxyflurane
COLLEGIUM PHARMACEUTICAL, INC
Unstable Angina
1 trial -
Tigecycline
Wyeth is now a wholly owned subsidiary of Pfizer
Skin Diseases, Bacterial
1 trial -
Tinoridine HCl
Takeda
Pain
1 trial -
Tiotropium 'Respimat' 5 mcg
Universal Integrated
Chronic Obstructive Airway Disease
1 trial -
Tirofiban hydrochloride sodium chloride injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Branch Atheromatous Disease
1 trial -
Tirzepatide
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Tirzepatide
Grace Therapeutics
Prader-Willi Syndrome
1 trial -
Tislelizumab
The First People's Hospital of Lianyungang
Advanced NSCLC
1 trial -
Tislelizumab + cisplatin + paclitaxel
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Tocilizumab
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
Tocilizumab
Shanghai Zhongshan Hospital
Takayasu Arteritis
1 trial -
Tofacitinib and Acitretin Capsules.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Cutaneous Amyloidosis
1 trial -
Tofacitinib with methotrexate
Pfizer
Rhematoid Arthritis
1 trial -
Tolvaptan
Otsuka Beijing Research Institute
Hyponatremia and Extracellular Fluid in Cirrhotic
1 trial -
Topical Anesthetic
Hospital Authority, Hong Kong
Radial Artery Spasm
1 trial -
Topiramate
United Therapeutics Europe Ltd
Alcohol Dependence
1 trial -
Topiramate
Janssen Cilag International NV
Epilepsy
1 trial -
Topiramate
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Alcohol Dependence
1 trial -
Topiramate
United Therapeutics Europe Ltd
Traumatic Brain Injury (TBI)
1 trial -
Topiramate
United Therapeutics Europe Ltd
PTSD
1 trial -
Toripalimab
Coherus Oncology
Nasopharyngeal Cancer Recurrent
1 trial -
Toujeo
Almirall, S.A.
Diabetes Mellitus, Type 2
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs